A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

April 24, 2025

Study Completion Date

April 24, 2025

Conditions

Pain

Interventions

DRUG

SUZ

Powder for oral administration.

Trial Locations (1)

Senopsys, LLC, Woburn

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT06834009 - A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists | Biotech Hunter | Biotech Hunter